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Title: Best practices for MRI Systematic Reviews and Meta-Analyses  
Abstract 
As defined by the Cochrane Collaboration, a systematic review is a review of evidence with a clearly 
formulated question that uses systematic and explicit methods to identify, select and critically appraise 
relevant primary research, and to extract and analyze data from the studies that are included in the 
review. Meta-analysis is a statistical method to combine the results from primary studies that accounts 
for sample size and variability to provide a summary measure of the studied outcome. Systematic 
reviews of diagnostic test accuracy present unique methodological and reporting challenges not present 
in systematic reviews of interventions. This review provides guidance and further resources highlighting 
current best practices in methodology and reporting of systematic reviews of diagnostic test accuracy, 
with a specific focus on challenges and opportunities for MRI imaging.  
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Introduction 
Systematic reviews, when well reported and performed with methodological rigor, represent 
valuable summaries of existing evidence about risk factors for specific medical conditions, the 
effectiveness of interventions or the performance of medical tests (1-3). The Cochrane Collaboration 
defines a systematic review as “a review of the evidence on a clearly formulated question that uses 
systematic and explicit methods to identify, select and critically appraise relevant primary research, and 
to extract and analyze data from the studies that are included in the review” (1).  
Five key characteristics of a systematic review are: (a) a clearly stated set of objectives with pre-
defined eligibility criteria for studies; (b) an explicit, reproducible methodology; (c) a systematic search 
that attempts to identify all studies that would meet the eligibility criteria; (d) an assessment of the 
validity of the findings of the included studies, for example through the assessment of risk of bias; (e) a 
systematic presentation, and synthesis, of the characteristics and findings of the included studies (1). 
Frequently, systematic reviews will apply meta-analysis. Meta-analysis is a statistical method to 
combine the results from primary studies that accounts for sample size and variability to provide a 
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summary measure of the studied outcome (1). The term systematic review will be used henceforth to 
describe systematic reviews that may or may not contain a meta-analysis. 
Systematic reviews can be used to aggregate data from multiple relatively small or underpowered 
studies to provide a more precise and more informative estimate of the effectiveness of an intervention 
or the accuracy of a diagnostic test (4,5). Additionally, meta-analysis may explore sources of 
heterogeneity among the observed effects of an intervention or the accuracy of a diagnostic test (2,3).  
There are several fundamental differences between systematic reviews of randomized trials of 
interventions and reviews of test accuracy studies. When reviewing effectiveness studies, summary 
measures in meta-analysis usually estimate the benefit from treatment, in terms of, for example, a 
reduction in morbidity or mortality. In systematic reviews of test accuracy, the summary measure 
represents the ability of an index test to detect the target condition: a disease, or disease stage. This is 
typically expressed in terms of the index test’s sensitivity and specificity.  
Magnetic resonance imaging (MRI) is a powerful diagnostic tool and with a wide array of 
clinical, mainly diagnostic, applications (2-10). While MRI guided procedures (interventional MRI), 
began in the 1990s, image-guided interventions are still dominated by ultrasound, fluoroscopy and 
computed tomography (CT) (11). There are several challenges to MR-guided interventions, such as 
longer acquisition times, increased cost of MRI safe equipment, and the technical complexity of 
performing a procedure within a superconducting MRI system. These challenges presently limit their 
widespread use (11). Due to these limitations, the overwhelming majority of systematic reviews within 
MRI have focused on diagnostic test accuracy.  
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In this paper, we discuss specific features of systematic reviews of MR studies, with focus on 
diagnostic test accuracy systematic review methods. 
 
Author Resources 
 Published systematic reviews of test accuracy studies have been shown to be often of 
questionable quality and prone to shortcomings in methodology and reporting (12-15). Several resources 
exist for authors for both methodological guidance and reporting best practices. The Cochrane 
Handbook for DTA (Diagnostic Test Accuracy) Reviews (freely available on-line) provides 
methodological guidance in the areas of protocol development, developing inclusion criteria, execution 
of a search strategy, assessment of mythological quality of included studied, analyzing and presenting 
results along with the interpretation of results (16). For reporting of DTA systematic reviews, PRISMA-
DTA and PRISMA-DTA for abstracts should be used.  However, if a systematic review is being 
performed for an MRI guided intervention, it would be more appropriate to use the Cochrane Handbook 
for Systematic Reviews of Interventions to guide methodology, and the original PRISMA statement to 
guide reporting (1,17). 
 
Forming the clinical question 
A critical step in planning a systematic review is forming a relevant clinical question.  In order 
for a systematic review to advance knowledge, the question should be one for which there is clinical 
equipoise.  As such, if there are multiple well-executed randomized trials, or several well-executed (low 
risk of bias) diagnostic accuracy studies on a topic with similar conclusions, there may be little to be 
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gained from performing a systematic review.  Similarly, if a high quality systematic review has recently 
been published on the topic (or a protocol is registered and one is underway), duplicating these efforts 
may not be contributory (12). The ideal scenario is one in which: a) there is clinical equipoise b) there 
are a large number of well designed, well reported studies with varying conclusions c) there is no recent 
systematic review on the topic (or one underway). These conditions provide not only the relevant 
clinical question, but also the substrate with which to answer it.  Identifying a relevant question can be 
challenging, and requires consideration of the present body of evidence, including primary research, as 
well as clinical practice guidelines.  Often, the ‘future research’ identified in the discussion section of 
studies, or ‘uncertainty- low level evidence’ cited in guidelines can be helpful indices regarding topics 
that are ripe for systematic review. 
 Once a question is identified, a detailed, structured format allows readers to best understand the 
question.  The ‘PICO’ (Patient, Intervention, Comparator, Outcome) format for systematic reviews of 
interventions, or ‘Patients-Index Test-Target Condition’ for diagnostic accuracy systematic reviews 
provides a useful framework with which to structure review questions (1,18-20). Each category of the 
‘PIT’ question should contain sufficient detail such that the readers can interpret whether the study 
findings are generalizable to their practice.   
Consider a systematic review aiming to evaluate the diagnostic accuracy of MRI in detecting 
extra-prostatic extension (EPE) in patients with prostate cancer.  For the ‘Patient’ category relevant 
details might include: species (human); age (adult); gender (male); prior testing (prostate cancer detected 
by trans-rectal biopsy with Gleason score of >7) (21).   For the ‘Index Test’ category, the general 
principle is to provide enough detail such that the reader could replicate the test in clinical practice (22).  
Relevant ‘index test’ details for the prostate study might include, but not be limited to:  field strength 
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(e.g. 1.5 versus 3T), contrast agent used (e.g. dynamic contrast enhancement performed with 
extracellular contrast agent with temporal resolution of at least 10 seconds), slice thickness for T2 WI 
(<4mm), use of endo-rectal coil, use of diffusion weighed imaging (DWI), and which b-values used 
(23,24).  For the ‘target condition’ category, readers need to be aware whether the disease, or target 
condition is similar to that encountered in their patient population.  As such, for the prostate example, 
the ‘target condition’ is prostate cancer with extension beyond the capsule of the prostate detected at 
histopathology (25). 
Part of defining a clinical question relates to deciding what the main outcome of the systematic 
review will be.  There are two major categories of diagnostic accuracy systematic reviews—those 
evaluating a single index test, and those comparing multiple index tests.  Evaluating accuracy of a single 
test can aim to: a) gain a greater understanding of test precision (via more narrow confidence intervals) 
b) to identify sources for variability in accuracy.  For evaluations of comparative accuracy, it is 
important to consider tests that might be used at a similar point in the clinical pathway (26).  For 
example, it may not be optimal to compare prostate specific antigen (PSA) with MRI for screening of 
prostate cancer when each might be positioned at separate places in the diagnostic pathway—PSA being 
a triage test, with MR being a confirmatory test.  Rule-out triage tests generally value sensitivity over 
specificity, and confirmatory tests require greater specificity.  As such, head to head comparison of PSA 
to MRI would not be relevant since different components of accuracy are emphasized, and the intended 
use may be different  (21).   
 
Updating Systematic Reviews 
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 Updating systematic reviews is an essential part of keeping knowledge synthesis contemporary.  
Deciding when to update a systematic review can be challenging and depends on the nature and extent 
of research done since a systematic review was completed (1). For MRI systematic reviews, indicators 
that an update may be necessary are typically linked to advances in technical parameters.  For example, 
if a systematic review was performed on studies with lower field strength, or without the benefit of 
multi-parametric acquisition, and subsequent studies have demonstrated substantially different data from 
those of the original systematic review, an update may be fruitful. 
 
Search and inclusion 
Best practices for searching for MRI systematic reviews have much in common with systematic 
reviews in general.  Searching multiple databases (e.g. MEDLINE, Embase, and Google Scholar), and 
searching the reference lists of included studies are recommended. Collaboration with an experience 
librarian to ensure that search terms are constructed based on the index test and target condition is 
recommended.   
Use of methodologic search filters for diagnostic accuracy studies is not recommended since they 
have been shown to miss important studies (16,27).  The need to search for unpublished data is 
controversial and may not always be necessary in the case of well-studied, well-established MRI 
techniques.  However, in cases where a technique is new, or rapidly evolving, search of relevant 
conference abstracts (e.g. ISMRM, RSNA), and clinical trial databases may be appropriate in order to 
ensure that all relevant studies are included.  Inclusion of studies in languages other than English can be 
a very labor-intensive process re: translation.  As such, the risk of missing relevant studies if English is 
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used as a search limitation should be considered (28).  For topics with a very regional focus (e.g. 
diseases endemic to certain parts of the world) it may be necessary to ensure that studies from these 
regions are included. 
Eligibility of studies retrieved during the search process should be guided by the ‘PIT’ question.  
The inclusion criteria should ensure that the appropriate patients, index test and target condition are 
being evaluated.   Returning to the prostate MRI example used above, the following inclusion criteria 
based on the ‘PIT’ question could be applied: 
To be eligible for inclusion, studies must fulfill all of the following criteria: 
1. Human male patients with biopsy proven Gleason >7 prostate cancer. 
2. Index test applied was MRI with 3T magnet, dynamic contrast enhancement of <10s 
temporal resolution, >2 planes of T2WI with <4mm slice thickness, application of DWI 
using >3 b-values. 
3. Target condition is extra-prostatic extension of tumor identified by surgical pathology 
following prostatectomy. 
Additional criteria for inclusion can go beyond the ‘PIT’ question and consider aspects such as study 
quality (e.g. prospective design, consecutive or random selection of patients, and date of publication).  
Authors need to be cognizant of striking a balance between inclusion criteria that are too broad vs. strict.  
Criteria that are too broad may include studies that are so heterogeneous that meaningful comparison is 
not possible.  In contrast, criteria that are too narrow risks limiting the pool of potential studies, thereby 
restricting opportunity to evaluate for sources of variability (29). 
 
Data extraction 
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Ideally data are extracted from primary studies using data extraction forms defined and piloted 
throughout the development of the study protocol. It is recommended to perform data extraction 
independently by two or more extractors with disagreements reconciled by mutual agreement or through 
discussion with a third reviewer to reach a final decision. Data extraction forms should be piloted on a 
sample of primary studies and refined as necessary. This is intended to assess both completeness of the 
forms, ensure clarity of user instructions and optimize inter-extractor consistency. The collected data can 
then be compared across extractors to assess inter-extractor consistency (1).  
Identification of relevant data items, methods of the data extraction (e.g. independently or in 
duplicate), along with definitions of the information to be extracted and the processes for obtaining 
missing data from the investigators of the eligible studies should all be specified. Characteristics of the 
participants, clinical setting, study design, and classification of the target conditions, index tests, and 
reference standards are crucial for the assessment of test accuracy and possible sources of heterogeneity 
(19).  
 
Quality assessment 
Interpretation of systematic reviews is largely dependent on the quality of the included studies. 
Although quality assessment is essential in any systematic review, diagnostic accuracy systematic 
reviews require a specific tool, as study design of test accuracy research differs from interventional 
studies. The QUADAS-2 tool is the recommended tool for systematic quality assessment of diagnostic 
accuracy studies (30,31). QUADAS-2 consists of four domains: (1) patient selection, (2) index test, (3) 
reference standard, and (4) flow and timing. All domains are evaluated for risk of bias, and the first three 
This article is protected by copyright. All rights reserved.
domains are also assessed for concerns regarding applicability. Risk of bias refers to flaws or limitations 
in the design or conduct of a study. Concerns with regard to applicability refer to differences between 
the clinical features of the included study compared with the review question, including patient 
characteristics, setting, definitions of the target condition, and application or interpretation of the index 
test. For example, in a recent review of DWI to assess treatment response in locally advanced uterine 
cervical cancer, the authors found the spectrum of patients included in three of nine studies was not 
representative of the patients who would receive the test in clinical practice (greater than 75% of patients 
with stage IIb or higher disease) (32). 
As each review question may require different approaches for quality assessment, it is important 
to tailor the QUADAS-2 tool by adding or omitting signalling questions. Review authors should 
consider omitting any item that does not apply to the review question. For example, in imaging studies, 
if the index test is not interpreted based on a specific threshold, it may not be worthwhile considering 
this particular issue. The apparent diffusion coefficient (ADC) threshold would be relevant in DWI to 
indicate the presence or absence or degree of restricted diffusion and thus this signalling question would 
be relevant, however in detection of labrum tears threshold effects may not be relevant (5). Upon 
agreement of the reviewers with regard to the content of the tool, two independent investigators should 
perform a quality assessment pilot process.  
 Preferably, quality assessment should be performed by at least two independent authors. Risk of 
bias can be designated as either ‘low’, if all signaling questions within the same domain are answered 
with ‘yes’;  ‘high’, if any of the signaling question is answered with ‘no’; or ‘unclear’, if risk of bias 
assessment is hampered by a lack of reported data (22). Concerns with regard to applicability are not 
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based on signaling questions, but represent an overall judgment for a specific domain, rated as ‘low’, 
‘high’, or ‘unclear’.  
It is not recommended to calculate an overall quality score based on the QUADAS-2 results, as 
the relevance of different sources of bias and concerns of applicability may differ between review 
questions (33). In general, a study may be regarded as having a low risk of bias or low concern of 
applicability when judged as ‘low’ on all risk of bias and applicability domains, respectively. If one of 
the domains was designated ‘high’ or ‘unclear’, the study may be judged to have risk of bias or as 
having concerns regarding applicability.  
The results of the QUADAS-2 assessment are typically presented in a tabular fashion, listing the 
results of the individual studies for each domain. To better guide the reader, it is key to also provide for 
a narrative summary of the quality assessment, explaining how the quality of the included studies may 
affect the overall interpretation of the review results.  
Authors may only include studies at low risk of bias without concerns regarding applicability for 
the primary analysis of the review. Subgroup or sensitivity analyses may be used to explore whether the 
diagnostic accuracy estimates vary across studies judged as ‘low’, ‘high’, or ‘unclear’ for all or for 
separate domains. 
 
Data analysis 
 In order to ensure reproducibility of a review and transparency of reporting, any decisions made 
with respect to data handling need to be reported (19). How studies were grouped for meta-analysis 
should be reported (e.g. whether included studies were stratified by field strength and/or sequences used) 
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along with how primary study level data was handled (e.g. multiple thresholds or multiple index test 
readers). 
In most meta-analyses of diagnostic test accuracy, data are dichotomized to “disease present” 
and “disease absent” to produce a single two by two table from each study. However, there are 
circumstances when a test report results are on a continuous scale, i.e. ADC map values, a cut point or 
threshold can be chosen above which the test results are “positive” and below which test results are 
classed as “negative”. For example, in ADC maps values less than 1.0 to 1.1 x 10-3 mm/s (or 1000-1100 
x 10-6 mm2/s) are often selected to indicate restriction in adults. However, this can be problematic if 
different studies report different thresholds, i.e. studies report test performance at multiple thresholds 
(34). In this scenario, one option is to pool all studies regardless of threshold and perform subgroup- 
analysis or meta-regression to determine if threshold is a contributor to variability in accuracy.  
Alternatively, Riley et al. have extended the bivariate-normal meta-analysis model first proposed by 
Reitsma et al. (35). Their model accounts for within-study correlations in the sensitivities and 
specificities at various thresholds (34). In addition, their model allows for relationships between test 
performance metrics at the between-study level (34). 
It has been shown that systematic reviews of test accuracy studies in imaging journals 
infrequently report how they handle primary studies with multiple readers (36). This deficiency makes it 
difficult to determine exactly how primary study data was input into the meta-analysis and thus difficult 
to reproduce results. Optimal methods for handling multiple reader data are currently not available but 
multi-level hierarchical models accounting for between-observer variability within studies, and between-
study variability, provided multiple reader data is reported consistently at the primary study level are 
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needed. (36) Using such models, all readers would be included in the meta-analysis, inter-observer 
variability at the primary study level would not be lost, and a single study would not be over-represented 
(36). Until such optimal methods become available, authors are encouraged to report how they handle 
multiple reader data for primary studies in their meta-analysis. 
The statistical model and software package used for meta-analysis should be explicitly reported 
(19). Unlike a meta-analysis of randomized trials, which typically produces a single summary effect 
measure, meta-analyses of diagnostic test accuracy studies typically produce two summary measures, 
such as sensitivity and specificity. These two summary measures are correlated and statistical methods 
used for meta-analysis need to account for this. Due to this unique challenge in diagnostic test accuracy 
meta-analyses, hierarchical methods, which account for this correlation, have been developed (35,37). In 
a comparison between traditional univariate methods and the recommended hierarchical methods, the 
univariate methods were found to overestimate diagnostic accuracy and provide narrower confidence 
intervals compared to hierarchical methods (13). A recent review by Cronin et al. provides a useful 
appendix describing software for diagnostic test accuracy meta-analysis (38). 
 
Assessing variability (heterogeneity) 
Students typically learn that the negative and positive predictive value of a test vary, depending 
on the prevalence of the target condition in those being tested, but that sensitivity and specificity are 
stable. The diagnostic accuracy is not a fixed property of a test, as the performance of test varies. 
Sensitivity and specificity differ, sometimes dramatically, depending on where the test is used: the 
setting (primary care or tertiary care, for example), the type of patients (young or old, obese or thin), or 
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whether they have had prior tests (39). These characteristics will also vary depending on the definition 
of the target condition, and may vary with the type of clinical reference standard researchers rely on. 
This variability poses two types of challenges in systematic reviews: how best to express the 
variability, and how best to explain the variability. To express the variability, a meta-analysis of 
diagnostic accuracy studies will almost always rely on a random-effects model. Such as random-effects 
model assumes that the sensitivity and specificity vary between studies, not just by chance, but in a more 
systematic way, where each application has its own sensitivity and specificity. A random-effects does 
not try to estimate that setting-specific sensitivity and specificity, but aims to describe it in terms of a 
distribution, with a mean and a variance. In fact, there are two, correlated distributions: one for the 
sensitivity and one for the specificity. The magnitude of the respective variances is an expression of the 
variability in accuracy.  
For explaining and handling variability, several approaches exist. One approach is to limit the 
variability by having a narrow review question. Rather than having a review question that focuses on a 
general target condition, such as “detecting metastases” one could add a specification of the type of 
patients (e.g. patients with colorectal cancer), the setting (e.g. tertiary care cancer center), and maybe 
even the specific type of MRI (e.g. MR liver using a hepatobiliary contrast agent) that one wants to 
evaluate in the review. 
A second approach is to group included studies in such a way that they highlight likely sources 
of between-study variability beyond chance. Methodological guidance can be found in the Cochrane 
Handbook for DTA Reviews, specifically in Chapter 10 (16).  One method is to perform a subgroup 
analysis: performing a meta-analysis of the results from on a selected group of studies, once again 
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defined by a narrower definition of the type of test, patients, setting, target condition, or a combination 
thereof. An example of a recently published subgroup analysis is presented in Figure 1 (3). An 
alternative is meta-regression. Here a single meta-analysis is performed, based on all included studies, 
but indicator variables are used to mark studies that differ in an identifiable way. By including these 
variables in the random-effects model, one can estimate systematic differences in the mean, variance and 
covariance between studies. An example of a recently published meta-regression from a review of MRI 
in paediatric patients with suspected appendicitis is presented in Figure 2 (4). This meta-regression 
showed that the addition of contrast has no impact on diagnostic accuracy and the use of DWI was 
detrimental to diagnostic accuracy, perhaps guiding future selection of MRI protocols for this target 
condition. 
There are several potentially serious limitations to subgroup analysis and meta-regression for 
exploring sources of variability. In many systematic reviews, the number of studies is limited, and any 
results from such additional analyses may be imprecise. Second, studies may differ in multiple ways, 
and it can be difficult to pinpoint the most likely source of variability. Third, these approaches only work 
for between-study differences. Within study sources of variability cannot easily be incorporated. 
Results from studies can also differ in a systematic way when some studies were designed or 
conducted with shortcomings, whereas others where not. In that case, studies with methodological 
deficiencies may yield biased results. Bias should not be a reflection of variability in accuracy, and the 
best way of handling risk of bias is probably to identify such studies using QUADAS-2 and to perform 
meta-analysis only on studies that are at low risk of bias (29). 
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Presenting results 
 Recently an extension of the Preferred Reporting Items for Systematic Reviews and Meta-
Analyses (PRISMA) has been developed specific to diagnostic test accuracy: PRISMA-DTA (19). 
PRISMA-DTA and PRISMA-DTA for abstracts user-friendly checklists for authors and reviewers are 
freely available on-line from the EQUATOR network website (40).  This reporting guideline was 
created to account for the challenges posed by systematic reviews of diagnostic test accuracy studies. 
Such reviews should be using the PRISMA-DTA checklist as their reporting guideline rather than the 
original PRISMA statement (17,19).  
The number of search results screened, assessed for eligibility at the full-text level, excluded at 
full-text review (with reasons), and included in the systematic review and meta-analysis should be 
included. This information should be displayed in a flow diagram. A template is provided in Figure 3 
(17). 
Results from the risk of bias and concerns regarding applicability assessment (e.g. QUADAS-2) 
should be presented granularly for each domain for each study, either in the full-text of the manuscript 
or online as supplemental information (30). An example is provided in Figure 4. Plots showing the 
proportion of studies in low, unclear, and high risk of bias categories per domain are less informative. 
An overall ‘quality score’ should not be used (33). 
For each included primary study information should be provided: a) participant characteristics 
(presentation, previous testing); b) clinical setting; c) study design; d) target condition definition; e) 
index test(s); f) reference standard(s); g) sample size; h) funding sources (19). This provides a clear 
summary of the key characteristics included primary studies. For each analysis in each primary study 
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(e.g. unique combination of index test, reference standard and positivity threshold) 2x2 data should be 
provided along with estimates of diagnostic accuracy (e.g. sensitivity and specificity) along with 
associated confidence intervals. The estimates of diagnostic accuracy and confidence intervals should be 
displayed graphically, as points in forest plots or in receiver operating characteristic (ROC) space (19). 
An example is shown in Figure 5 (41).  Displaying the accuracy estimates with confidence intervals for 
each primary study in a forest plot allows for a quick visual assessment of heterogeneity. From the data 
presented in Figure 5 it is clear the primary studies are quite homogeneous and it is unsurprising that 
meta-regression found no significant differences in accuracy among several chosen covariates. 
Results from each meta-analysis including, at minimum, summary estimates of diagnostic 
accuracy and associated confidence intervals should be presented.  This data can be presented on a forest 
plot or an HSROC curve. The forest plot (Figure 5), familiar to many readers, will display the 
sensitivity and specificity separately, although we know they are correlated accuracy measures. The 
HSROC plot will display the summary estimate and confidence region in ROC space, showing 
sensitivity and specificity together in two-dimensional space.  
If using the bivariate random-effects or HSROC models, parameter estimates can be used to 
calculate and plot the summary ROC curve, the summary operating point (the summary estimates of 
sensitivity and specificity in ROC space), a 95% confidence region around the summary point, and a 
95% prediction region (16). The 95% confidence region in ROC space expresses the uncertainty about 
the location of the mean diagnostic performance will fall. The 95% prediction region in ROC space is 
the area within which 95% of all estimates from primary study diagnostic accuracies can be expected 
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(16,19). An example of a HSROC curve displaying the summary estimate, along with 95% confidence 
and prediction regions is shown in Figure 6 (2). 
The Cochrane Handbook for DTA reviews recommends providing a summary of findings table. 
(16) This is a concise method to summarize the findings of a review. The table should include 
participants, clinical setting, index test(s), reference standard(s) and role in the clinical pathway. Any 
concerns arising from the assessment of risk of bias and applicability or from excessive heterogeneity 
should be noted within the table. For each unique combination of index test or positivity threshold a 
unique row should include the number of studies and participants, estimates of diagnostic accuracy 
generated by the review along with associated uncertainty estimates (e.g. confidence intervals) and 
information regarding disease prevalence from either the studies in the review or external sources (16). 
A sample summary of findings table is shown in Figure 7 (42).  
In comparative diagnostic accuracy reviews, comparing two or more index tests against a 
reference standard, the table should include the number of studies and participants arising from direct 
and indirect comparisons, estimates of diagnostic accuracy for each test with associated uncertainty 
estimates, and P-values for the comparison of the index tests being compared. This will allow to reader 
to determine significant differences in test accuracy (16). 
 
Discussion and conclusions 
Any systematic review should provide a balanced discussion and conclusions. The main findings 
of the review should be summarized including the diagnostic accuracy of the reviewed index test(s) and 
factors affecting variability in test accuracy. Limitations of the review should be discussed both from the 
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perspective of included studies (e.g. risk of bias and concerns regarding applicability) and the review 
process (e.g. incomplete retrieval of identified research, limited search strategy). 
Authors should be cautioned only to form conclusions that are justified by the results of the 
systematic review. It has been shown that overinterpretation (often referred to as “spin”) of diagnostic 
test accuracy systematic review results is problematic and not infrequent (14). Caution should be 
exercised when stating a positive conclusion about the index test reviewed in the presence of concerns 
regarding risk of bias (and/or applicability) or variable test performance (heterogeneity); these 
limitations of the evidence should be explicitly mentioned, both in the abstract and the full text. In the 
setting of a comparative systematic review, test superiority should only be claimed when results of 
statistical comparison (e.g. meta-regression) identify that the index test accuracy differs significantly.  
 
Future directions for imaging systematic reviews 
Currently, most diagnostic accuracy studies estimate the accuracy of a single study compared to 
a reference standard. However, what is required are studies that compare the accuracy of competing 
tests, performed in all study participants, against the reference standard (43). Such studies allow strong 
inferences about whether one test is as accurate as or more accurate than other tests. This then enables 
clear recommendations to be made about test selection and consideration of the tests suitable for use 
(43). Because of the limitations of the primary literature, most systematic reviews and meta-analyses of 
diagnostic test accuracy estimate only the accuracy of an individual test (43). Reviews of comparative 
diagnostic accuracy would allow comparisons between tests which can then inform decision-making 
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(43). In addition, more studies that evaluate tests in well-defined clinical diagnostic pathways are also 
needed (43).  
 
Diagnostic Test Accuracy Network Meta-analysis 
Network meta-analysis (NMA) allows an indirect comparison between two treatments or tests of 
interest obtained through more than one common comparator. Recently, a method for quantitatively 
addressing both direct and indirect comparisons of several competing interventions has been developed 
by Lu and Ades (44). This has further improved NMA techniques, with the advantages of strengthening 
inference of the relative efficacy of two treatments (or accuracy of two tests), by including both “direct” 
and “indirect” comparisons and facilitating simultaneous inference regarding all treatments or tests, in 
order, for example, to select the best treatment or test, i.e. a ranking of the treatments or tests (44).  
Prior to 2008, very few systematic reviews containing NMAs were published (45). The 
hypothetical example shown in Figure 8A, shows a review with multiple direct comparison meta-
analyses (i.e. an umbrella review), whereas Figure 8B shows a network plot. NMA can be performed 
within either a frequentist or a Bayesian framework (45). Bayesian analyses are performed with Markov 
Chain Monte Carlo (MCMC) simulations.  This allows repeated reproduction of the model until 
convergence. The Bayesian approach has several advantages. These include a straightforward way of 
making predictions, and the possibility of incorporating different sources of uncertainty. In addition, 
Bayesian analyses are more flexible statistical models, and are probably more applicable to NMA of 
diagnostic imaging studies (45).  
Network meta-analyses are increasingly popular in comparative effectiveness research. However, 
they can be difficult to understood and interpret (46). Graphical tools can present results of statistical 
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analyses in a way that is more easily understood (46). These include network plots as described below 
and in Figure 8B (46). In a network plot, the nodes (circles) represent the interventions or technologies 
under evaluation (45). The lines that connect the interventions represent the comparisons. The set of 
direct and indirect statistical comparisons is the NMA (45). Node size is dependant on the number of 
studies for each intervention (45). Line width is dependant on the number of direct evidence studies 
(45). A contribution plot is used to show the influence of each direct piece of evidence. The size of each 
square is proportional to the weight attached to each direct summary effect, usually shown on the 
horizontal axis, for the estimation of each network summary effects, usually shown on the vertical axis 
(46). In an inconsistency plot, each closed loop in the network is assessed. Triangular networks formed 
by three treatments/technologies all compared with each other are assessed (46). An inconsistency factor 
(IF) is calculated with a 95% confidence interval. This is the absolute difference between direct and 
indirect estimates (46). A z-test for the IF can also be calculated. The IF is the logarithm of the ratio of 
two odds ratios (RoR) from direct and indirect evidence in the loop (46). Values close to 1 for the RoR 
mean that the two sources are in agreement (46). The comparison-adjusted funnel plot is similar to the 
funnel plot that assesses the presence of small-study effects in a meta-analysis. The ‘comparison-
adjusted’ funnel plot presents the difference between the study-specific effect sizes from the 
corresponding comparison-specific summary effect (46). Heterogeneity within a NWM can be visually 
displayed using a predictive intervals plot. Instead a forest plot of the estimated summary effects along 
with their confidence intervals and their corresponding predictive intervals (PrI) for all comparisons can 
be displayed in one plot. This forest plot summarizes the relative mean effects, predictions and the 
impact of heterogeneity on each comparison (46). Visual tools can also be used to rank interventions. 
The ranking of the treatments or tests should be done using probabilistic methods, for example using the 
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surface under the cumulative ranking curve (SUCRA). These methods take into account the estimated 
effect sizes and their accompanying uncertainty (47). The SUCRA is used to provide a hierarchy of the 
interventions (46). The larger the SUCRA value, the better the rank of the intervention (46). 
Multidimensional scaling (MDS) is an alternative approach to rank the competing interventions (46). A 
clustered ranking plot of the interventions in a network based on cluster analysis of SUCRA values for 
two different outcomes such as efficacy and acceptability can also be performed (46). 
An example of a diagnostic test accuracy network meta-analysis to compare the diagnostic value 
of four imaging methods (MRI, positron emission tomography (PET), CT, and DWI) for diagnosing 
lymph node metastases in cervical cancer (48). In this study, the authors performed a traditional pairwise 
meta-analysis of studies that directly compared different diagnostic modalities (48). Secondly, the 
authors drew a network evidence diagram (network plot), whereby each node represented a different 
imaging method, node size reflected sample size, and the thickness of the line between nodes 
represented the number of included studies. A node splitting analysis showing a pair-wise comparison of 
the imaging methods is shown in Figure 9 (48). Thirdly, the authors conducted a Bayesian NMA 
comparing different diagnostic modalities (48). A Bayesian approach adopting probability values 
summarized as surface under the cumulative ranking curve (SUCRA) was the most effective method 
(48). Another example of a NMA studied the outcomes of non-invasive diagnostic modalities for the 
detection of coronary artery disease (49). In this study, again, the authors performed a traditional pair-
wise meta-analysis of studies that compared the different diagnostic modalities with associated network 
plots (49). 
 
Individual Patient/Participant Data (IPD) Meta-analysis 
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Meta-analyses of individual patient/participant data (IPD) have been performed for therapeutic 
studies often using data from randomized controlled trials (RCTs). It has been shown that some of these 
IPD meta-analyses have influenced the selection of comparators and participants, sample size 
calculations, analysis and interpretation of subsequent trials, and the conduct and analysis of ongoing 
trials (50). Systematic reviews and meta-analyses of IPD have also been used to inform clinical 
guideline recommendations (51). Individual patient/participant data meta-analyses of test accuracy 
studies can also be performed and have advantages over conventional meta-analyses (52). They acquire 
the raw data from the studies (52). They can help elucidate the incremental information provided by 
testing over and above that already known from history and examination (52). Conventional meta-
analyses usually assess a single diagnostic test compared to a clinical reference standard, often in 
isolation from the previous tests. Meta-analyses of IPD potentially allow assessment of for a complete 
diagnostic sequence starting with history, examination and testing, considering all the testing. This takes 
into account the redundancy of information (52). An IPD meta-analysis can be performed 
retrospectively or prospectively. In a retrospective IPD meta-analyses, authors are contacted and invited 
to supply raw data from their primary study. Ideally, an IPD meta-analysis should be performed 
prospectively as this ensures uniformity of data and its quality. Prospective IPD meta-analysis are often 
referred to the as the gold standard of meta-analyses. 
Multivariable analyses of IPD meta-analysis allow for the redundancy of information in tests and 
is less likely to overestimate incremental test accuracy (52). These analyses can also help determine the 
optimal sequence in which tests especially the more advanced tests should be performed (52). Because 
the unit of analysis is at the patient level rather than the study level, there is greater power to explore 
heterogeneity and perform meta-regression analyses. Association across patient-level characteristics or 
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between patient level and study level characteristics can be explored reducing ecological bias (53). In 
addition, IPD meta-analyses may allow the development or evaluation of diagnostic algorithms for 
individual patients. They also allow the analysis of continuous test results rather than the dichotomous 
classification (with loss of information) that is generally used in reports of diagnostic tests (53). 
 
Conclusion 
 Herein we have provided an overview of methodological and reporting best practices for MRI 
systematic reviews. Systematic reviews are regarded as high-level evidence, which can influence clinical 
decision-making and healthcare policy making. Methodological rigor and complete reporting are crucial 
to ensure the systematic reviews these decisions are based on are of the highest possible quality. The 
methodological guidance in this review is by no means exhaustive and we encourage authors to refer to 
the Cochrane Handbook for DTA Reviews if further guidance is sought (16). Similarly the PRISMA-
DTA statement should be referenced for complete reporting requirements of DTA systematic reviews 
(19). 
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Figure Captions 
 
Figure 1: Example of subgroup analysis results. Figure reprinted from: Duncan JK, Ma N, 
Vreugdenburg TD, Cameron AL, Maddern G. Gadoxetic acid-enhanced MRI for the characterization of 
hepatocellular carcinoma: A systematic review and meta-analysis. J Magn Reson Imaging 
2017;45(1):281-290. 
 
Figure 2: Example of meta-regression results. Figure reprinted from: Kim JR, Suh CH, Yoon HM, et al  
Performance of MRI for suspected appendicitis in pediatric patients and negative appendectomy rate: A  
systematic review and meta-analysis. J Magn Reson Imaging 2018;47(3):767-778. 
 
Figure 3: PRISMA flow diagram template 
 
Figure 4: Sample QUADAS-2 risk of bias and applicability results table 
 
Figure 5: Sample table showing 2x2 data, estimates of sensitivity and specificity (with confidence  
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intervals) and associated forest plots for included primary studies. Figure reprinted from: Repplinger 
MD, Levy JF, Peethumnongsin E, et al. Systematic review and meta-analysis of the accuracy of MRI to 
diagnose appendicitis in the general population. J Magn Reson Imaging 2015. 
 
Figure 6: HSROC curve displaying summary estimate, 95% confidence region and 95% prediction 
region. Figure printed from: Choi SH, Kim SY, Park SH, et al. Diagnostic performance of CT, 
gadoxetate disodium-enhanced MRI, and PET/CT for the diagnosis of colorectal liver metastasis: 
Systematic review and meta-analysis. J Magn Reson Imaging 2017. 
 
Figure 7: Summary of findings table. Figure reprinted from: Giljaca V, Gurusamy KS, Takwoingi Y, et 
al. Endoscopic ultrasound versus magnetic resonance cholangiopancreatography for common bile duct 
stones. Cochrane Database Syst Rev 2015(2):CD011549. 
 
Figure 8A: A schematic representation of a review with a direct comparison meta-analyses (otherwise 
known as an umbrella review). In this hypothetical example, there are 7 index test options (ultrasound, 
computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET), 
single-photon emission computed tomography (SPECT), PET-MRI and SPECT-MRI) compared to one 
reference test, catheter angiography.  This results in 13 comparisons options. 
 
Figure 8B: A schematic representation of a network review with the same data. Each test is shown by a 
node (circle) of different color, which represents the test being evaluated. Node size is dependant on the 
number of studies for each test. More studies result in a larger node. The lines or links that connect the 
tests (nodes) represent the comparisons. Line width is dependant on the number of direct evidence 
studies. The thicker the line the more direct evidence studies. 
 
Figure 9: Node splitting plot of the diagnostic value of 4 imaging methods in the diagnosis of lymph 
node metastasis in patients with CC. A, Magnetic resonance imaging. B, Positron emission tomography. 
C, Computer tomography; D, diffusion-weighted imaging. CC indicates cervical cancer. Figure reprinted 
from: Luo Q, Luo L, Tang L. A Network Meta-Analysis on the Diagnostic Value of Different Imaging 
Methods for Lymph Node Metastases in Patients With Cervical Cancer. Technol Cancer Res Treat 
2018;17:1533034617742311. 
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